logo
Plus   Neg
Share
Email

PepsiCo Extends Global Partnership With UEFA Champions League Through 2024 - Quick Facts

PepsiCo, Inc. (PEP) announced Tuesday that its partnership with football's elite UEFA Champions League has been extended for the 2021/22 - 2023/24 seasons. This follows PepsiCo's recent announcement of its multi-year premier partnership with UEFA Women's football through 2025, now presenting a unified and significant presence across football's prestigious league.

SodaStream joins PepsiCo's starting brand line-up for its UEFA Champions League activation, alongside the Pepsi trademark, including Pepsi MAX, Lay's and Gatorade. Doritos, Ruffles, Lipton and 7UP will also support.

The partnership includes a focus to advance equality and environmental causes, working together to deliver increasingly sustainable events and to make plastic waste reduction and recycling a key priority.

Additionally, PepsiCo and the UEFA Foundation for Children will continue to collaborate on programs that harness the unifying power of football for communities in need.

PepsiCo and UEFA have also pledged ongoing and increased support for the UEFA Champions League Final Opening Ceremony presented by Pepsi.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration is hastening its efforts to make available more at-home testing options in response to the ongoing COVID-19 pandemic. All At-Home Covid-19 Tests being used now are authorized only for emergency use, and not cleared or fully approved by the FDA. The recent granting of EUA for the Quidel Corp.'s QuickVue At-Home COVID-19 Test is one example. Dollar Tree Inc. (DLTR) Wednesday reported a profit for the fourth-quarter that climbed 309 percent from last year, while Wendy's Co. (WEN) posted a profit that grew about 46.0 percent from the prior year. Dollar Tree has increased its share repurchase authorization by $2.0 billion. Wendy's expects profit for fiscal year 2021 to be below analysts' expectations. Medical devices company Boston Scientific Corp. (BSX) agreed Wednesday to acquire the global surgical business of Israel-based Lumenis LTD from an affiliate of Baring Private Equity Asia (BPEA) for an upfront cash payment of $1.07 billion, subject to closing adjustments. Lumenis is a privately-held...
Follow RTT